Details for Patent: 4,338,325
✉ Email this page to a colleague
Summary for Patent: 4,338,325
Title: | PGI.sub.2 Pharmacologically acceptable salts |
Abstract: | The present invention relates to PGI.sub.2 pharmacologically acceptable salts, having pharmacological activity. Particularly, the compounds described herein are useful as platelet aggregation inhibitors. |
Inventor(s): | Johnson; Roy A. (Kalamazoo, MI), Lincoln; Frank H. (Portage, MI), Pike; John E. (Kalamazoo, MI) |
Assignee: | The Upjohn Company (Kalamazoo, MI) |
Application Number: | 06/200,690 |
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; |
Drugs Protected by US Patent 4,338,325
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,338,325
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2112577 | ⤷ Sign Up | |||
Australia | 3788278 | ⤷ Sign Up | |||
Australia | 508851 | ⤷ Sign Up | |||
Australia | 527238 | ⤷ Sign Up | |||
Belgium | 851122 | ⤷ Sign Up | |||
Belgium | 869378 | ⤷ Sign Up | |||
Canada | 1160627 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |